These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen. Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Sousa Lobo JM; Amaral MH Pharm Dev Technol; 2017 May; 22(3):336-349. PubMed ID: 28240141 [TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability. Liu R; Liu Z; Zhang C; Zhang B J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401 [TBL] [Abstract][Full Text] [Related]
4. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables. Rathod VR; Shah DA; Dave RH Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896 [TBL] [Abstract][Full Text] [Related]
5. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
6. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery. Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662 [TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
8. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Khurana S; Jain NK; Bedi PM Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071 [TBL] [Abstract][Full Text] [Related]
9. Alpha-lipoic acid-loaded nanostructured lipid carrier: sustained release and biocompatibility to HaCaT cells in vitro. Wang J; Xia Q Drug Deliv; 2014 Aug; 21(5):328-41. PubMed ID: 24144220 [TBL] [Abstract][Full Text] [Related]
10. Novel nanostructured lipid carriers loading Apigenin for anterior segment ocular pathologies. Bonilla-Vidal L; Espina M; García ML; Baldomà L; Badia J; González JA; Delgado LM; Gliszczyńska A; Souto EB; Sánchez-López E Int J Pharm; 2024 Jun; 658():124222. PubMed ID: 38735632 [TBL] [Abstract][Full Text] [Related]
11. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery. Cirri M; Bragagni M; Mennini N; Mura P Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833 [TBL] [Abstract][Full Text] [Related]
12. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Soni K; Rizwanullah M; Kohli K Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147 [TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers for site-specific drug delivery. Khosa A; Reddi S; Saha RN Biomed Pharmacother; 2018 Jul; 103():598-613. PubMed ID: 29677547 [TBL] [Abstract][Full Text] [Related]
14. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin. Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323 [TBL] [Abstract][Full Text] [Related]
15. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015 [TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers-based thermosensitive eye drops for enhanced, sustained delivery of dexamethasone. Mo Z; Ban J; Zhang Y; Du Y; Wen Y; Huang X; Xie Q; Shen L; Zhang S; Deng H; Hou D; Chen Y; Lu Z Nanomedicine (Lond); 2018 Jun; 13(11):1239-1253. PubMed ID: 29949466 [TBL] [Abstract][Full Text] [Related]
17. Fabrication and Characterization of Timolol Maleate and Brinzolamide Loaded Nanostructured Lipid Carrier System for Ocular Drug Delivery. Shrivastava N; Khan S; Baboota S; Ali J Curr Drug Deliv; 2018; 15(6):829-839. PubMed ID: 29189155 [TBL] [Abstract][Full Text] [Related]
18. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
19. Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies. Ravani L; Esposito E; Bories C; Moal VL; Loiseau PM; Djabourov M; Cortesi R; Bouchemal K Int J Pharm; 2013 Oct; 454(2):695-702. PubMed ID: 23792467 [TBL] [Abstract][Full Text] [Related]
20. Preclinical Assessment of Steroidal Nanostructured Lipid Carriers Based Gels for Atopic Dermatitis: Optimization and Product Development. Nagaich U; Gulati N Curr Drug Deliv; 2018; 15(5):641-651. PubMed ID: 28925874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]